Screener
Opus Genetics IRD Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Opus Genetics’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034084
FAQ
- What is Opus Genetics's shares (diluted)?
- Opus Genetics (IRD) reported shares (diluted) of 86.9M in Q1 2026.
- How has Opus Genetics's shares (diluted) changed year-over-year?
- Opus Genetics's shares (diluted) increased by 156.4% year-over-year, from 33.9M to 86.9M.
- What is the long-term trend for Opus Genetics's shares (diluted)?
- Over 4 years (2021 to 2025), Opus Genetics's shares (diluted) has grown at a 42.2% compound annual growth rate (CAGR), from 56.3M to 230.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Opus Genetics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude